Informazione:
Errore:
ID
12579
Descrizione
Study to Assess Hemodynamic Effects, Safety and Tolerability of Chimeric Natriuretic Peptide (CD-NP) in Patients With Stabilized Acute Heart Failure (AHF); ODM derived from: https://clinicaltrials.gov/show/NCT00699712
collegamento
https://clinicaltrials.gov/show/NCT00699712
Keywords
versioni (1)
- 02/12/15 02/12/15 -
Caricato su
2 dicembre 2015
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Eligibility Acute Decompensated Heart Failure NCT00699712
Eligibility Acute Decompensated Heart Failure NCT00699712
- StudyEvent: Eligibility
Similar models
Eligibility Acute Decompensated Heart Failure NCT00699712
- StudyEvent: Eligibility
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
hospitalization for ahf
Item
hospitalization for acute heart failure
boolean
C0184666 (UMLS CUI [1])
C0264714 (UMLS CUI [2])
C0264714 (UMLS CUI [2])
hemodynamic monitoring
Item
in need of hemodynamic monitoring
boolean
C0161959 (UMLS CUI [1])
administration of radiographic contrast agent or acute contrast-induced nephropathy
Item
administration of intravenous radiographic contrast agent within 7 days prior to screening or planned iv contrast media administration in the 4 days after screening or acute contrast-induced nephropathy at the time of screening
boolean
C2917425 (UMLS CUI [1])
C0268775 (UMLS CUI [2])
C0268775 (UMLS CUI [2])
current or planned treatment with any iv therapies
Item
current or planned treatment with any iv therapies, including diuretics, vasodilators (including nesiritide), vasopressin antagonists, positive inotropic agents and vasopressors, or mechanical support
boolean
C2347852 (UMLS CUI [1])
current or planned ultrafiltration, hemofiltration, or dialysis within 7 days of screening
Item
current or planned ultrafiltration, hemofiltration, or dialysis within 7 days of screening
boolean
C0041612 (UMLS CUI [1])
C0019014 (UMLS CUI [2])
C0011946 (UMLS CUI [3])
C0019014 (UMLS CUI [2])
C0011946 (UMLS CUI [3])
pulmonary disease
Item
significant pulmonary disease
boolean
C0024115 (UMLS CUI [1])
valvular heart disease
Item
known valvular heart disease
boolean
C0018824 (UMLS CUI [1])
organ transplant recipient or patient currently listed for transplant
Item
any organ transplant recipient or patient currently listed for transplant or admitted for any transplantation.
boolean
C0040732 (UMLS CUI [1])
major surgery within 30 days of screening
Item
major surgery within 30 days of screening
boolean
C0679637 (UMLS CUI [1])
other major disability or disease with expected survival less than 6 months
Item
other major disability or disease with expected survival less than 6 months.
boolean
C0679247 (UMLS CUI [1])
major neurologic event, including cerebrovascular events
Item
major neurologic event, including cerebrovascular events, in the 60 days prior to screening
boolean
C0027765 (UMLS CUI [1])
C0852396 (UMLS CUI [2])
C0852396 (UMLS CUI [2])
acute coronary syndrome
Item
clinical diagnosis of acute coronary syndrome within 45 days of screening
boolean
C0948089 (UMLS CUI [1])
troponin t ≥ 3 times the upper limit of normal at screening
Item
troponin t ≥ 3 times the upper limit of normal at screening
boolean
C0523953 (UMLS CUI [1])
significant arrhythmias
Item
significant arrhythmias
boolean
C0003811 (UMLS CUI [1])
cardiomyopathy
Item
acute myocarditis or hypertrophic obstructive, restrictive, or constrictive cardiomyopathy
boolean
C0155686 (UMLS CUI [1])
C0878544 (UMLS CUI [2])
C0878544 (UMLS CUI [2])
liver dysfunction
Item
liver function abnormality
boolean
C0086565 (UMLS CUI [1])
participation in another trial or administration of an investigational drug or implantation of investigational device
Item
administration of an investigational drug or implantation of investigational device, or participation in another trial, within 30 days prior to screening
boolean
C2348568 (UMLS CUI [1])